Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome associated with neonatal epidermolysis bullosa acquisita

Pediatric Dermatology

Volumn 32, Issue 3, 2015, Pages e74-e77

  Bis, Sabina ^a   Maguiness, Sheilagh M ^b   Gellis, Stephen E ^b   Schneider, Lynda C ^b   Lee, Pui Y ^b   Notarangelo, Luigi D ^b   Keles, Sevgi ^b   Chatila, Talal A ^b   Schmidt, Birgitta A ^b   Miller, Daniel D ^c  

^a Harvard Combined Dermatology Residency Program   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 7; IMMUNOGLOBULIN E; METHYLPREDNISOLONE; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3; IMMUNOSUPPRESSIVE AGENT;

ACUTE KIDNEY FAILURE; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; COOMBS POSITIVE HEMOLYTIC ANEMIA; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; EPIDERMOLYSIS BULLOSA ACQUISITA; FAILURE TO THRIVE; FOLLICULITIS; HUMAN; HYPOTHYROIDISM; IMMUNOFLUORESCENCE; INCONTINENTIA PIGMENTI; IPEX SYNDROME; KERATINOCYTE; KIDNEY FUNCTION; KILLER CELL; LABORATORY TEST; LYMPHOCYTE SUBPOPULATION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NEWBORN; PERIPHERAL EDEMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKIN DEFECT; TACHYPNEA; VESICULAR RASH; BONE MARROW TRANSPLANTATION; DIABETES MELLITUS, TYPE 1; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC DISEASES, X-LINKED; IMMUNE SYSTEM DISEASES;

BONE MARROW TRANSPLANTATION; DIABETES MELLITUS, TYPE 1; DIAGNOSIS, DIFFERENTIAL; DIARRHEA; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMOLYSIS BULLOSA ACQUISITA; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC DISEASES, X-LINKED; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNOSUPPRESSIVE AGENTS; INFANT, NEWBORN; MALE;

EID: 84929674554     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/pde.12550     Document Type: Article

References (8)

1. Halabi-Tawil M, Ruemmele FM, Fraitag S, et al., Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Br J Dermatol 2009; 160: 645-651.
2. Verbsky JW, Chatila TA,. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases. Curr Opin Pediatr 2013; 25: 708-714.
3. d'Hennezel E, Bin Dhuban K, Torgerson T, et al., The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2012; 49: 291-302.
4. Wildin RS, Smyk-Pearson S, Filipovich AH,. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002; 39: 537-545.
5. Nieves DS, Phipps RP, Pollock SJ, et al., Dermatologic immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Arch Dermatol 2004; 140: 466-472.
6. McGinness JL, Bivens MMC, Greer KE, et al., Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) associated with pemphigoid nodularis: a case report and review of the literature. J Am Acad Dermatol 2006; 55: 143-148.
7. Ferguson PJ, Blanton SH, Saulsbury FT, et al., Manifestations and linkage analysis in X-linked autoimmunity-immunodeficiency syndrome. Am J Med Genet 2000; 90: 390-397.
8. Olaiwan A, Chandesris MO, Fraitag S, et al., Cutaneous findings in sporadic and familial autosomal dominant hyper-IgE syndrome: a retrospective, single-center study of 21 patients diagnosed using molecular analysis. J Am Acad Dermatol 2011; 65: 1167-1172.